| Translating new magnetic resonance imaging insights in to treatment options and clinical trial design in multiple sclerosis | UCL Institute of Neurology | MSSoc | £2.5M | 2009 | Completed |
| The MS Society/University of Edinburgh Translational Research Centre | University of Edinburgh | MSSoc | £2.1M | 2007 | Completed |
| The Edinburgh Centre for MS Research | University of Edinburgh | MSSoc | £2.0M | 2015 | Completed |
| Cambridge Centre for Myelin Repair (renewal) | University of Cambridge | MSSoc | £1.8M | 2016 | Completed |
| The ms and pd tissue bank at imperial college london | Associated with Imperial College London · Università di Siena, Policlinico le Scotte - Istituto di Scienze Neurologiche ed Unità Operativa Malattie Neurometaboliche | MSSoc | £1.3M | 2014 | Completed |
| MS-STAT2: A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo in secondary progressive multiple sclerosis, in slowing the progression of disability | University College London | MSSoc | £1.2M | 2017 | Completed |
| UK MS Register Extension 2018 | Swansea University | MSSoc | £402K | 2018 | Completed |
| Vestibular Rehabilitation in Multiple Sclerosis: improving vertigo, mobility and quality of life of people with MS. (VeRMiS) | Associated with University of Plymouth · Università di Padova, Clinica Neurologica | MSSoc | £300K | 2018 | Completed |
| ROS signalling and CNS remyelination | University of Cambridge | MSSoc | £297K | 2019 | Completed |
| Life-style, Exercise and Activity Package for People living with Progressive Multiple Sclerosis | Cardiff University | MSSoc | £293K | 2018 | Completed |
| Imaging Remyelination in the Central Nervous System | University of Cambridge | MSSoc | £282K | 2019 | Completed |
| UK MS Register - extension for further funding | Associated with Fondazione Istituto Neurologico Nazionale Casimiro Mondino - IRCCS, Divisione di Neuropsichiatria Infantile · Swansea University | MSSoc | £270K | 2017 | Completed |
| Novel cellular models to study oligodendrocyte-mediated axonal support | Associated with University of Bristol · University of Glasgow · Università di Trieste, Dipartimento di Fisiologia e Patologia | MSSoc | £254K | 2020 | Completed |
| Expression profiling in clonally expanded immune cells | Associated with Fondazione Centro San Raffaele, Istituto Scientifico Ospedale San Raffaele · University of Cambridge · University of Nottingham | MSSoc | £253K | 2019 | Completed |
| A Feasibility Trial of Neuromodulation with Connectivity-Guided Intermittent Theta Burst Stimulation for Cognitive Impairment in MS | University of Nottingham | MSSoc | £245K | 2020 | Completed |
| Examining the amelioration of MS during pregnancy at the single cell level to identify novel therapeutic targets | University of Oxford | MSSoc | £243K | 2019 | Completed |
| Advanced MRI to investigate progression in MS | Associated with Institute of Neurology, UCL · Università di Padova, Clinica Neurologica | MSSoc | £241K | 2018 | Completed |
| Molecular mechanisms of neurodegeneration in progressive multiple sclerosis | University of Oxford | MSSoc | £233K | 2020 | Completed |
| Restoring oxygenation to the inflamed CNS | Institute of Neurology, UCL | MSSoc | £223K | 2018 | Completed |
| How does ageing-associated niche stiffening disrupt nucleus mechanotransduction signaling and suppresses the regenerative capacity of adult CNS progenitor cells? | University of Cambridge | MSSoc | £200K | 2019 | Completed |